223 related articles for article (PubMed ID: 2839917)
1. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients.
Chou SW; Norman DJ
Transplantation; 1988 Jul; 46(1):89-93. PubMed ID: 2839917
[TBL] [Abstract][Full Text] [Related]
2. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors.
Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J
Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730
[TBL] [Abstract][Full Text] [Related]
3. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation.
Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ
Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients.
Chou SW
N Engl J Med; 1986 May; 314(22):1418-23. PubMed ID: 3010114
[TBL] [Abstract][Full Text] [Related]
5. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
Preiksaitis JK; Sandhu J; Strautman M
Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.
Pollak R; Barber PL; Prusak BF; Mozes MF
Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201
[TBL] [Abstract][Full Text] [Related]
7. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
Milbradt H; Flik J; Stangel W; Heigel R
Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
[TBL] [Abstract][Full Text] [Related]
8. Viral infections in renal transplant donors and their recipients: a prospective study.
Balfour HH; Slade MS; Kalis JM; Howard RJ; Simmons RL; Najarian JS
Surgery; 1977 May; 81(5):487-92. PubMed ID: 191948
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
10. Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.
Hughes D; Hafferty J; Fulton L; Friend P; Devaney A; Loke J; Welsh KI; Handa A; Klenerman P
J Clin Virol; 2008 Feb; 41(2):92-5. PubMed ID: 18032098
[TBL] [Abstract][Full Text] [Related]
11. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.
Chou S; Kim DY; Scott KM; Sewell DL
J Clin Microbiol; 1987 Jan; 25(1):52-5. PubMed ID: 3025251
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients.
Chou SW
J Infect Dis; 1989 Jul; 160(1):16-21. PubMed ID: 2543709
[TBL] [Abstract][Full Text] [Related]
14. The transplanted kidney as a source of cytomegalovirus infection.
Ho M; Suwansirikul S; Dowling JN; Youngblood LA; Armstrong JA
N Engl J Med; 1975 Nov; 293(22):1109-12. PubMed ID: 171567
[TBL] [Abstract][Full Text] [Related]
15. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.
Singh N; Dummer JS; Kusne S; Breinig MK; Armstrong JA; Makowka L; Starzl TE; Ho M
J Infect Dis; 1988 Jul; 158(1):124-31. PubMed ID: 2839576
[TBL] [Abstract][Full Text] [Related]
16. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?
Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D
J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496
[TBL] [Abstract][Full Text] [Related]
17. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation.
Smiley ML; Wlodaver CG; Grossman RA; Barker CF; Perloff LJ; Tustin NB; Starr SE; Plotkin SA; Friedman HM
Transplantation; 1985 Aug; 40(2):157-61. PubMed ID: 2992130
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation.
Keenan RJ; Lega ME; Dummer JS; Paradis IL; Dauber JH; Rabinowich H; Yousem SA; Hardesty RL; Griffith BP; Duquesnoy RJ
Transplantation; 1991 Feb; 51(2):433-8. PubMed ID: 1847251
[TBL] [Abstract][Full Text] [Related]
19. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-associated cytomegalovirus infections.
Adler SP
Rev Infect Dis; 1983; 5(6):977-93. PubMed ID: 6318291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
